Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.938 | 1.24e-16 | 1.33e-04 | 1.36e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
RNF40 | 9810 | 2 | -2.082 | 2.938 | 25 | Yes | - |
NCBP1 | 4686 | 6 | -2.510 | 3.149 | 40 | Yes | Yes |
NXF1 | 10482 | 10 | -2.426 | 3.538 | 65 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
[ PARN ] | 5073 | 1 | -1.333 | 2.938 | 10 | - | - |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
SRSF3 | 6428 | NXF1 | 10482 | pp | -- | int.I2D: MINT, HPRD; int.Mint: MI:0407(direct interaction), MI:0915(physical association) |
NCBP1 | 4686 | RNF40 | 9810 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BioGrid, HPRD, VidalHuman_core; int.HPRD: yeast 2-hybrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
NCBP1 | 4686 | NXF1 | 10482 | pp | -- | int.Mint: MI:0914(association) |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | NXF1 | 10482 | pp | -- | int.Intact: MI:0914(association) |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
NCBP1 | 4686 | PARN | 5073 | pp | -- | int.I2D: MINT; int.Mint: MI:0407(direct interaction) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005654 | nucleoplasm | 4.13e-07 | 5.96e-03 | 3.374 | 7 | 64 | 1082 |
GO:0010467 | gene expression | 7.26e-07 | 1.05e-02 | 3.845 | 6 | 45 | 669 |
GO:0006406 | mRNA export from nucleus | 5.94e-06 | 8.56e-02 | 6.300 | 3 | 4 | 61 |
GO:0044822 | poly(A) RNA binding | 1.05e-05 | 1.52e-01 | 3.187 | 6 | 50 | 1056 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.69e-05 | 3.88e-01 | 7.946 | 2 | 2 | 13 |
GO:0000398 | mRNA splicing, via spliceosome | 1.15e-04 | 1.00e+00 | 4.874 | 3 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 1.24e-04 | 1.00e+00 | 4.839 | 3 | 17 | 168 |
GO:0031124 | mRNA 3'-end processing | 2.94e-04 | 1.00e+00 | 6.254 | 2 | 2 | 42 |
GO:0008380 | RNA splicing | 3.05e-04 | 1.00e+00 | 4.398 | 3 | 22 | 228 |
GO:0006369 | termination of RNA polymerase II transcription | 3.38e-04 | 1.00e+00 | 6.154 | 2 | 2 | 45 |
GO:0005515 | protein binding | 3.85e-04 | 1.00e+00 | 1.260 | 9 | 198 | 6024 |
GO:0000166 | nucleotide binding | 4.44e-04 | 1.00e+00 | 4.214 | 3 | 13 | 259 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0009451 | RNA modification | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0003723 | RNA binding | 9.98e-04 | 1.00e+00 | 3.813 | 3 | 18 | 342 |
GO:0060242 | contact inhibition | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0005829 | cytosol | 1.39e-03 | 1.00e+00 | 1.946 | 6 | 86 | 2496 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.79e-03 | 1.00e+00 | 3.520 | 3 | 30 | 419 |
GO:0060913 | cardiac cell fate determination | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0030529 | ribonucleoprotein complex | 2.08e-03 | 1.00e+00 | 4.839 | 2 | 5 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.15e-03 | 1.00e+00 | 4.813 | 2 | 4 | 114 |
GO:0033503 | HULC complex | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0045292 | mRNA cis splicing, via spliceosome | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 3.74e-03 | 1.00e+00 | 4.408 | 2 | 7 | 151 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0016607 | nuclear speck | 4.82e-03 | 1.00e+00 | 4.220 | 2 | 12 | 172 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0000339 | RNA cap binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0033523 | histone H2B ubiquitination | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0031625 | ubiquitin protein ligase binding | 5.15e-03 | 1.00e+00 | 4.170 | 2 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 5.15e-03 | 1.00e+00 | 4.170 | 2 | 11 | 178 |
GO:0042405 | nuclear inclusion body | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0005634 | nucleus | 5.94e-03 | 1.00e+00 | 1.299 | 7 | 159 | 4559 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 10 |
GO:0004518 | nuclease activity | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 |
GO:0005845 | mRNA cap binding complex | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0004535 | poly(A)-specific ribonuclease activity | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 2 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 3 | 11 |
GO:0010390 | histone monoubiquitination | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 11 |
GO:0008334 | histone mRNA metabolic process | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0016071 | mRNA metabolic process | 7.98e-03 | 1.00e+00 | 3.845 | 2 | 8 | 223 |
GO:0071480 | cellular response to gamma radiation | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0000346 | transcription export complex | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0005487 | nucleocytoplasmic transporter activity | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 3 | 14 |
GO:0001824 | blastocyst development | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 15 |
GO:0008134 | transcription factor binding | 9.34e-03 | 1.00e+00 | 3.727 | 2 | 18 | 242 |
GO:0016070 | RNA metabolic process | 9.71e-03 | 1.00e+00 | 3.698 | 2 | 8 | 247 |
GO:0043274 | phospholipase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0007292 | female gamete generation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0017075 | syntaxin-1 binding | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0032757 | positive regulation of interleukin-8 production | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 20 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0034660 | ncRNA metabolic process | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0031047 | gene silencing by RNA | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 25 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 3 | 25 |
GO:0035329 | hippo signaling | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 5 | 26 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 26 |
GO:0003730 | mRNA 3'-UTR binding | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 |
GO:0000387 | spliceosomal snRNP assembly | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 |
GO:0043565 | sequence-specific DNA binding | 1.85e-02 | 1.00e+00 | 3.212 | 2 | 11 | 346 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 5 | 30 |
GO:0042594 | response to starvation | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 32 |
GO:0006355 | regulation of transcription, DNA-templated | 2.02e-02 | 1.00e+00 | 2.270 | 3 | 43 | 997 |
GO:0006446 | regulation of translational initiation | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 4 | 36 |
GO:0035019 | somatic stem cell maintenance | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 6 | 40 |
GO:0050434 | positive regulation of viral transcription | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 5 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 4 | 46 |
GO:0006986 | response to unfolded protein | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 3 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 4 | 53 |
GO:0003677 | DNA binding | 3.43e-02 | 1.00e+00 | 1.981 | 3 | 49 | 1218 |
GO:0005643 | nuclear pore | 3.50e-02 | 1.00e+00 | 4.813 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 6 | 59 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 2 | 61 |
GO:0000151 | ubiquitin ligase complex | 3.86e-02 | 1.00e+00 | 4.669 | 1 | 1 | 63 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.11e-02 | 1.00e+00 | 4.580 | 1 | 6 | 67 |
GO:0016032 | viral process | 4.14e-02 | 1.00e+00 | 2.585 | 2 | 26 | 534 |
GO:0010468 | regulation of gene expression | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 2 | 68 |
GO:0003729 | mRNA binding | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 5.06e-02 | 1.00e+00 | 4.271 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 8 | 86 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 5 | 92 |
GO:0005770 | late endosome | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 2 | 93 |
GO:0005737 | cytoplasm | 5.81e-02 | 1.00e+00 | 1.089 | 5 | 124 | 3767 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.73e-02 | 1.00e+00 | 2.197 | 2 | 39 | 699 |
GO:0007050 | cell cycle arrest | 7.48e-02 | 1.00e+00 | 3.692 | 1 | 5 | 124 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.60e-02 | 1.00e+00 | 3.669 | 1 | 5 | 126 |
GO:0016055 | Wnt signaling pathway | 8.29e-02 | 1.00e+00 | 3.538 | 1 | 4 | 138 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.33e-02 | 1.00e+00 | 2.022 | 2 | 41 | 789 |
GO:0043005 | neuron projection | 9.38e-02 | 1.00e+00 | 3.352 | 1 | 3 | 157 |
GO:0005667 | transcription factor complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 17 | 175 |
GO:0032403 | protein complex binding | 1.09e-01 | 1.00e+00 | 3.130 | 1 | 6 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 22 | 184 |
GO:0016874 | ligase activity | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 4 | 214 |
GO:0003713 | transcription coactivator activity | 1.39e-01 | 1.00e+00 | 2.757 | 1 | 24 | 237 |
GO:0004842 | ubiquitin-protein transferase activity | 1.48e-01 | 1.00e+00 | 2.652 | 1 | 5 | 255 |
GO:0019901 | protein kinase binding | 1.81e-01 | 1.00e+00 | 2.338 | 1 | 18 | 317 |
GO:0008283 | cell proliferation | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 14 | 328 |
GO:0046982 | protein heterodimerization activity | 2.14e-01 | 1.00e+00 | 2.076 | 1 | 8 | 380 |
GO:0009986 | cell surface | 2.25e-01 | 1.00e+00 | 1.995 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.30e-01 | 1.00e+00 | 1.956 | 1 | 24 | 413 |
GO:0044267 | cellular protein metabolic process | 2.60e-01 | 1.00e+00 | 1.757 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.62e-01 | 1.00e+00 | 1.745 | 1 | 24 | 478 |
GO:0005730 | nucleolus | 2.73e-01 | 1.00e+00 | 0.966 | 2 | 66 | 1641 |
GO:0016020 | membrane | 2.83e-01 | 1.00e+00 | 0.931 | 2 | 46 | 1681 |
GO:0042803 | protein homodimerization activity | 3.16e-01 | 1.00e+00 | 1.429 | 1 | 19 | 595 |
GO:0008270 | zinc ion binding | 4.75e-01 | 1.00e+00 | 0.685 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 4.76e-01 | 1.00e+00 | 0.683 | 1 | 23 | 998 |
GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 31 | 1298 |
GO:0046872 | metal ion binding | 5.75e-01 | 1.00e+00 | 0.294 | 1 | 29 | 1307 |
GO:0005886 | plasma membrane | 8.31e-01 | 1.00e+00 | -0.688 | 1 | 49 | 2582 |